Research. Advocacy. Support.
We advance ovarian cancer research while supporting women and their families.
Know Your Risks
About 20 to 25 percent of women diagnosed with ovarian cancer have a hereditary tendency to develop the disease.
(June 23, 2017) A clinical trial published in the Journal of Clinical Oncology focused on a largely understudied area of cancer survivorship: chemotherapy-induced peripheral neuropathy (CIPN) in women. Forty seven percent of the 512 women in the trial reported CIPN an average of 6 years after their treatment ended. Symptoms of CIPN reported during the… More
According to recent reports, the Department of Health and Human Services (HHS) will soon seek to limit access to oral contraception benefits. “The proposed rule allowing employers to deny insurance coverage for birth control limits the application of oral contraceptives in preventive medicine, in particular, for ovarian cancer. Oral contraceptives have been shown to reduce… More
(June 1, 2017) A study, published last month in Gynecologic Oncology, focused on an area of ovarian cancer that is rarely talked about: the quality of life (QOL) for long term survivors of advanced stage ovarian cancer. Woman surviving 8.5 years or longer, who had anywhere from 0 recurrences to multiple recurrences, were given surveys… More
This is truly a can’t miss event—join us in Chicago for a weekend of hope, inspirat...July 7 @ 8:00 am - July 9 @ 5:00 pm EDT
OCRFA’s Super Saturday is a daylong shopping event that brings top luxury name brands in high ...July 29 @ 12:00 pm - 6:00 pm EDT
OCRFA’s indoor cycling event returns to Tampa, FL on September 9, 2017! Sign up to ride for a ...September 9 @ 10:00 am - 12:00 pm EDT